Years ago, a cardiologist suggested that I take Niacin to lower cholesterol. Now, a small but extremely closely watched study showed that niacin performed better than the active ingredient in some blockbuster drugs.
It isn’t often that a study involving a couple of hundred people shakes up medical science.
That’s what happened Monday, when doctors formally reported that lowly niacin, a B vitamin, did a significantly better job of shrinking artery plaque than a billion-dollar blockbuster called ezetimibe, the active ingredient in the cholesterol drugs Zetia and Vytorin.
